25% added
heart protection
is possible?
Really?

A groundbreaking 2018 study* proved that VASCEPA lowers your chance of a life-threatening cardiovascular event (such as a heart attack or stroke) by 25%^† when added to a statin.^‡
REDUCE-IT^® study N Engl J Med.* 2019;380(1):11-22.
^†In adults on maximally tolerated statins with TG ≥150 mg/dL and established CVD or diabetes and ≥2 CVD risk factors.
^‡In a clinical study, patients treated with VASCEPA and a statin had fewer cardiovascular (CV) events (17.2%) compared to those who took placebo (22%).

Icon of a heart representing Persistant Cardiovascular Risk (P-CVR), the cardiovascular risk that reminas even when taking a statin and managing cardiovascular risk factors.

How much ground did this study actually break?

When medical societies saw the results, they immediately recognized the active ingredient in VASCEPA, icosapent ethyl, in their guidelines.

Why? CV disease is an epidemic, and a 25% reduction in risk^‡ on top of statins is a very significant breakthrough.

To be clear, statins are still recommended for high cholesterol, but even with a statin, significant CV risk can remain. We call this:

Persistent Cardiovascular Risk (P-CVR):

The CV risk that remains even if you’re taking a statin and managing CV risk factors like high blood pressure and high cholesterol.

Ask your doctor about your individual risk.

^‡In a clinical study, patients treated with VASCEPA and a statin had fewer CV events (17.2%) compared to those who took placebo (22%).

Clear VASCEPA® (icosapent ethyl) capsule

Protect your heart
with an additional
25%
CV risk reduction^‡ when you add VASCEPA to your statin.

If you cannot take statins, talk to your doctor about
whether or not VASCEPA can help you.

^‡In a clinical study, patients treated with VASCEPA and a statin had fewer CV events (17.2%) compared to those who took placebo (22%).

How we got here

Landmark REDUCE-IT trial included over 8000 statin-treated patients with high triglycerides and lasted nearly 5 years
In addition to taking a statin, most patients were also taking medication to manage conditions like high blood pressure
In this study, patients treated with VASCEPA had fewer CV events (17.2%) compared to those who took placebo (22%)

How VASCEPA reduces CV risk

VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with heart disease or diabetes and other risk factors. The clinical effects of VASCEPA are believed to include multiple factors. The exact science of how VASCEPA works in your body is not fully understood, but years of clinical testing have led to proven clinical results in lowering P-CVR with VASCEPA. Ask your doctor about heart protection with VASCEPA.

Even if you’re taking a statin or other medications for high blood pressure, VASCEPA offers the additional CV protection your heart needs

Are you at greater risk than you think?

Take the quiz

Questions about taking FDA-approved VASCEPA capsules?

Taking VASCEPA

INDICATIONS

WHAT IS VASCEPA?

VASCEPA is a prescription medicine used:

along with certain medicines (statins) to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with heart (cardiovascular) disease, or diabetes and 2 or more additional risk factors for heart disease.
along with a low-fat and low-cholesterol diet to lower high levels of triglycerides (fats) in adults.

It is not known if VASCEPA changes your risk of having inflammation of your pancreas (pancreatitis).
It is not known if VASCEPA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

WHO SHOULD NOT TAKE VASCEPA?

Do not take VASCEPA if you are allergic to icosapent ethyl or any of the ingredients in VASCEPA.

What are the possible side effects of VASCEPA?
VASCEPA may cause serious side effects, including:

Heart rhythm problems (atrial fibrillation and atrial flutter). Heart rhythm problems which can be serious and cause hospitalization have happened in people who take VASCEPA, especially in people who have heart (cardiovascular) disease or diabetes with a risk factor for heart (cardiovascular) disease, or who have had heart rhythm problems in the past. Tell your doctor if you get any symptoms of heart rhythm problems such as feeling as if your heart is beating fast and irregular, lightheadedness, dizziness, shortness of breath, chest discomfort or you faint.
Possible allergic reactions if you are allergic to fish or shellfish. Stop taking VASCEPA and tell your doctor right away or get emergency medical help if you have any signs or symptoms of an allergic reaction.
Bleeding. Serious bleeding can happen in people who take VASCEPA. Your risk of bleeding may increase if you are also taking a blood thinner medicine.

If you have liver problems and are taking VASCEPA, your doctor should do blood tests during treatment.
The most common side effects of VASCEPA include:

Muscle and joint pain
Swelling of the hands, legs, or feet
Constipation
Gout
Heart rhythm problems (atrial fibrillation)

These are not all the possible side effects of VASCEPA. Call your doctor for medical advice about side effects. You may report adverse events (i.e. side effects) or product complaints by contacting AmarinConnect at 1-855-VASCEPA (1-855-827-2372), emailing [email protected], or calling the FDA at 1-800-FDA-1088.

Tell your doctor if you take medicines that affect your blood clotting (anticoagulants or blood thinners).

For more information on VASCEPA, click here to see the full Patient Information or call 1-855-VASCEPA (1-855-827-2372).

25% added heart protection is possible? Really?

How much ground did this study actually break?

Persistent Cardiovascular Risk (P-CVR):

Protect your heart with an additional 25% CV risk reduction‡ when you add VASCEPA to your statin.

If you cannot take statins, talk to your doctor about whether or not VASCEPA can help you.